Tvardi Therapeutics, Inc. (TVRD)

Latest Insider Confidence Score

2026Q1

50.0
Bearish

Company insider confidence (by quarter)

2014Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Csl Ltd — 7,396,770 Jul 25, 2023
Vifor (International) Ltd — 7,396,770 Oct 21, 2021
Vifor Pharma Ltd. — 7,396,770 Oct 21, 2021
Vifor Fresenius Medical Care Renal Pharma Ltd. — 7,396,770 Oct 21, 2021
Ruch Joshua 10% Owner 3,568,057 Apr 3, 2017

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 29, 2026 Feb 2, 2026 O'Brien Stephen Paul Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Jan 29, 2026 Feb 2, 2026 Conn Avi Daniel CFO Neutral 52.5 - 0.00% ✗ -
Jan 29, 2026 Feb 2, 2026 Kauh John Saewook M.D. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 29, 2026 Feb 2, 2026 Alibhai Imran Nizamudin CEO Neutral 52.5 - 0.00% ✗ -
Dec 16, 2025 Dec 18, 2025 O'Brien Stephen Paul Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Dec 16, 2025 Dec 18, 2025 Kauh John Saewook M.D. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 16, 2025 Dec 18, 2025 Conn Avi Daniel CFO Neutral 52.5 - 0.00% ✗ -
Dec 16, 2025 Dec 18, 2025 Alibhai Imran Nizamudin CEO Neutral 52.5 - 0.00% ✗ -
Jul 7, 2025 Aug 5, 2025 Tweardy Samuel David 10% Owner Neutral 27.5 -631,316 -100.00% ✗ -
Apr 15, 2025 May 2, 2025 HALL WALLACE L JR Director Neutral 90.0 +246,756 100.00% ✗ -
Apr 15, 2025 May 2, 2025 Wirk Shaheen Director Neutral 90.0 +439,194 100.00% ✗ -
May 2, 2025 Tweardy Samuel David 10% Owner Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Apr 21, 2025 Larson Jeffrey Leroy SVP, Research & Development Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Apr 21, 2025 O'Brien Stephen Paul Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Apr 21, 2025 Chen Yixin VP, Chem, Mfg and Ctrls Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Apr 21, 2025 Conn Avi Daniel CFO Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Apr 21, 2025 Kauh John Saewook M.D. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Apr 21, 2025 Alibhai Imran Nizamudin CEO Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Apr 21, 2025 Shiff Susan Ph.D. Director Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Apr 21, 2025 Wirk Shaheen Director Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Apr 21, 2025 WYZGA MICHAEL S Director Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Apr 21, 2025 Smith Cynthia Director Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Apr 21, 2025 Shah Sujal Director Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Apr 21, 2025 HALL WALLACE L JR Director Neutral 52.5 - 0.00% ✗ -
Apr 15, 2025 Apr 17, 2025 O'Brien Stephen Paul Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Apr 15, 2025 Apr 17, 2025 HALL WALLACE L JR Director Neutral 90.0 +246,756 100.00% ✗ -
Apr 15, 2025 Apr 17, 2025 Kauh John Saewook M.D. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 15, 2025 Apr 17, 2025 WYZGA MICHAEL S Director Neutral 52.5 - 0.00% ✗ -
Apr 15, 2025 Apr 17, 2025 Chen Yixin VP, Chem, Mfg and Ctrls Neutral 52.5 - 0.00% ✗ -
Apr 15, 2025 Apr 17, 2025 Wirk Shaheen Director Neutral 90.0 +443,385 100.00% ✗ -
Apr 15, 2025 Apr 17, 2025 Shah Sujal Director Neutral 52.5 - 0.00% ✗ -
Apr 15, 2025 Apr 17, 2025 Larson Jeffrey Leroy SVP, Research & Development Neutral 52.5 - 0.00% ✗ -
Apr 15, 2025 Apr 17, 2025 Conn Avi Daniel CFO Neutral 52.5 - 0.00% ✗ -
Apr 15, 2025 Apr 17, 2025 Alibhai Imran Nizamudin CEO Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 O'Brien Stephen Paul Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 WYZGA MICHAEL S Director Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 HALL WALLACE L JR Director Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Wirk Shaheen Director Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Conn Avi Daniel CFO Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Shah Sujal Director Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Kauh John Saewook M.D. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Alibhai Imran Nizamudin CEO Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Smith Cynthia Director Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Chen Yixin VP, Chem, Mfg and Ctrls Neutral 52.5 - 0.00% ✗ -
Apr 17, 2025 Larson Jeffrey Leroy SVP, Research & Development Neutral 52.5 - 0.00% ✗ -
Feb 28, 2025 Mar 4, 2025 Posner Christopher CEO Sell 42.5 -583 -4.26% ✓ $2.8K
Feb 28, 2025 Mar 4, 2025 Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Sell 46.3 -163 -2.22% ✓ $775.9
Feb 4, 2025 Feb 6, 2025 Posner Christopher CEO Sell 46.3 -372 -2.65% ✓ $1.8K
Nov 4, 2024 Nov 6, 2024 Posner Christopher CEO Sell 46.3 -3,668 -2.13% ✓ $1.1K
Aug 1, 2024 Aug 2, 2024 Posner Christopher CEO Sell 46.3 -4,149 -2.35% ✓ $1.5K
Jun 4, 2024 Jun 6, 2024 Boudreau Helen M Director Neutral 90.0 +150,647 100.00% ✗ -
Jun 4, 2024 Jun 6, 2024 von Moltke Lisa Director Neutral 90.0 +150,647 465.51% ✗ -
Jun 4, 2024 Jun 6, 2024 Ives Jeffrey L. Director Neutral 90.0 +150,647 314.91% ✗ -
Jun 4, 2024 Jun 6, 2024 Shiff Susan Ph.D. Director Neutral 90.0 +150,647 292.87% ✗ -
Jun 4, 2024 Jun 6, 2024 VOGELBAUM MARTIN Director Neutral 90.0 +301,295 274.62% ✗ -
May 2, 2024 May 6, 2024 Posner Christopher CEO Sell 46.3 -3,936 -2.18% ✓ $3K
Apr 5, 2024 Apr 9, 2024 Goncalves Joana CHIEF MEDICAL OFFICER Sell 42.5 -2,753 -4.91% ✓ $2.3K
Apr 5, 2024 Apr 9, 2024 Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Sell 42.5 -2,753 -3.03% ✓ $2.3K
Feb 29, 2024 Mar 4, 2024 Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Sell 42.5 -3,293 -3.49% ✓ $2.9K
Feb 29, 2024 Mar 4, 2024 Posner Christopher CEO Sell 42.5 -5,834 -3.13% ✓ $5.2K
Feb 29, 2024 Mar 4, 2024 Goncalves Joana CHIEF MEDICAL OFFICER Sell 37.5 -3,293 -5.54% ✓ $2.9K
Feb 8, 2023 Feb 12, 2024 Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Sell 33.8 -7,770 -7.61% ✓ $4.1K
Feb 8, 2023 Feb 12, 2024 Maynard Ryan D CFO Sell 15.0 -5,488 -40.65% ✓ $2.9K
Feb 8, 2023 Feb 12, 2024 Goncalves Joana CHIEF MEDICAL OFFICER Sell 30.0 -7,770 -11.57% ✓ $4.1K
Feb 8, 2024 Feb 12, 2024 Posner Christopher CEO Sell 23.8 -35,575 -16.03% ✓ $18.9K
Feb 1, 2024 Feb 5, 2024 Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Neutral 90.0 +13,500 15.24% ✗ -
Feb 1, 2024 Feb 5, 2024 Maynard Ryan D CFO Neutral 90.0 +13,500 100.00% ✗ -
Feb 1, 2024 Feb 5, 2024 Goncalves Joana CHIEF MEDICAL OFFICER Neutral 90.0 +13,500 25.15% ✗ -
Feb 1, 2024 Feb 5, 2024 Menzaghi Frederique Ph.D. CHIEF SCIENTIFIC OFF,SVP-R&D Neutral 85.0 +13,500 8.78% ✗ -
Feb 1, 2024 Feb 5, 2024 Posner Christopher CEO Sell 90.0 +57,519 34.98% ✓ $2.7K
Nov 2, 2023 Nov 3, 2023 Posner Christopher CEO Sell 46.3 -3,796 -2.26% ✓ $4.6K
Aug 3, 2023 Aug 4, 2023 Posner Christopher CEO Sell 45.0 -4,307 -2.50% ✓ $13.2K
Aug 2, 2023 Aug 4, 2023 Boudreau Helen M Director Neutral 52.5 - 0.00% ✗ -
Aug 4, 2023 Boudreau Helen M Director Neutral 52.5 - 0.00% ✗ -
Jul 25, 2023 CSL LTD 10% Owner Neutral 52.5 - 0.00% ✗ -
Jun 23, 2023 Jun 27, 2023 Terrillion Scott Sec'y; Chief Compliance & G.C. Sell 46.3 -2,483 -2.73% ✓ $8.7K
Jun 23, 2023 Jun 27, 2023 Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Sell 48.8 -2,993 -1.91% ✓ $10.5K
Jun 23, 2023 Jun 27, 2023 Goncalves Joana Chief Medical Officer Sell 42.5 -2,723 -4.83% ✓ $9.6K
Jun 1, 2023 Jun 5, 2023 von Moltke Lisa Director Neutral 90.0 +32,362 100.00% ✗ -
Jun 1, 2023 Jun 5, 2023 Shiff Susan Ph.D. Director Neutral 90.0 +32,362 169.65% ✗ -
Jun 1, 2023 Jun 5, 2023 Ives Jeffrey L. Director Neutral 90.0 +32,362 209.11% ✗ -
Jun 1, 2023 Jun 5, 2023 BAINS HARRISON M JR Director Neutral 90.0 +32,362 129.06% ✗ -
Jun 1, 2023 Jun 5, 2023 VOGELBAUM MARTIN Director Neutral 90.0 +64,724 143.87% ✗ -
May 5, 2023 May 9, 2023 Posner Christopher CEO Sell 45.0 -3,869 -2.19% ✓ $17K
Apr 4, 2023 Apr 6, 2023 Terrillion Scott Sec'y; Chief Compliance & G.C. Sell 45.0 -2,481 -2.65% ✓ $12.2K
Apr 4, 2023 Apr 6, 2023 Goncalves Joana Chief Medical Officer Sell 41.3 -2,481 -4.21% ✓ $12.2K
Apr 4, 2023 Apr 6, 2023 Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Sell 48.8 -2,733 -1.71% ✓ $13.4K
Mar 3, 2023 Mar 7, 2023 Posner Christopher CEO Sell 37.5 -5,987 -3.28% ✓ $58.1K
Mar 3, 2023 Mar 7, 2023 Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Sell 37.5 -6,802 -4.09% ✓ $66K
Mar 3, 2023 Mar 7, 2023 Terrillion Scott Sec'y; Chief Compliance & G.C. Sell 32.5 -6,256 -6.27% ✓ $60.7K
Mar 3, 2023 Mar 7, 2023 Goncalves Joana Chief Medical Officer Sell 28.8 -6,221 -9.56% ✓ $60.4K
Mar 1, 2023 Mar 3, 2023 Terrillion Scott Sec'y; Chief Compliance & G.C. Neutral 52.5 - 0.00% ✗ -
Mar 1, 2023 Mar 3, 2023 Maynard Ryan D CFO Neutral 52.5 - 0.00% ✗ -
Mar 1, 2023 Mar 3, 2023 Goncalves Joana Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 1, 2023 Mar 3, 2023 Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Neutral 52.5 - 0.00% ✗ -
Mar 1, 2023 Mar 3, 2023 Posner Christopher CEO Neutral 52.5 - 0.00% ✗ -
Feb 16, 2023 Feb 17, 2023 Goncalves Joana Chief Medical Officer Sell 41.3 -2,265 -3.36% ✓ $23.1K
Feb 2, 2023 Feb 3, 2023 Posner Christopher CEO Sell 45.0 -4,191 -2.25% ✓ $49.5K
Jan 2, 2023 Jan 19, 2023 von Moltke Lisa Director Neutral 52.5 - 0.00% ✗ -
Jan 17, 2023 Jan 19, 2023 Goncalves Joana Chief Medical Officer Sell 41.3 -2,265 -3.25% ✓ $24.5K